Replimune Group, Inc. — Director's Dealing 2025

Dec 11, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Replimune Group, Inc. (REPL)
CIK: 0001737953
Period of Report: 2025-12-09

Reporting Person: Dhingra Kapil (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-12-09	Common Stock	M	3169	$1.75	Acquired	3169	Direct
2025-12-09	Common Stock	S	3169	$10.40	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-12-09	Stock Option (right to buy)	$1.75	M	3169	Disposed	2026-01-21	Common Stock (3169)	Direct

Footnotes

F1: The reporting person exercised the option due to the upcoming expiration date of the option.

F2: All of the shares underlying this stock option vested on January 21, 2016.